Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dose Prediction for Antihypertensive Medications in Cirrhotic Patients
NCT07397481Phase 4Completed
- Sponsor
- Kafrelsheikh University
- Start
- Mar 2024
- Primary completion
- Mar 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of nebivolol, carvedilol in hypertension (HTN), Portal Hypertension (PH), sponsored by Kafrelsheikh University. Started Mar 2024; status: completed.
02
Drugs
nebivololcarvedilol
03
Conditions
hypertension (HTN)Portal Hypertension (PH)
Beyond the preview
Go deeper on NCT07397481.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07397481.